Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NOG | CLDX |
|---|---|---|
| Price | $24.13 | $31.86 |
| Change today | ▲ 0.42% | ▼ 2.24% |
| Market cap | $2.57B | $2.50B |
| Return, 3 months | +33.2% | -20.2% |
| Return, year to date | +19.1% | +17.3% |
| Return, 1 year | +2.4% | +20.8% |
| P/E (TTM) | -5.0 | -7.3 |
| P/B | 1.3 | 3.5 |
| P/E percentile vs own 5y | – | 92nd |
| Dividend yield | 7.46% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +18.5% | +115.6% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 51 | 37 |
| 30-day volatility | 35.3% | 50.5% |
| Max drawdown, 1 year | -41.4% | -30.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
